Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide. A multimethods analysis was performed as part of the GlobalSurg 3 study—a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital. Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3·85 [95% CI 2·58–5·75]; p<0·0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63·0% vs 82·7%; OR 0·35 [0·23–0·53]; p<0·0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer. Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised. National Institute for Health and Care Research.
Myeloid sarcoma of the breast is a rare malignancy, can be seen after bone marrow transplantation. Although there are no specific features for this malignancy which is difficult to diagnose, some common features draw attention in the published case reports. Since there is no consensus on the treatment of myeloid sarcoma of the breast, we aimed to explain our own diagnosis and treatment methods in this case report.
30 December 2024 in Medical Journal of Western Black Sea
Aim: We wanted to investigate whether the watch and wait method without surgery or surgery is superior in patients with rectal cancer receiving neoadjuvant treatment. Material and Methods: The clinical data of case above the age of 18 who were diagnosed with rectal tumors between 2018 and 2023 were retrospectively analyzed. Results: After neoadjuvant treatment, the mass disappeared completely in some case. All case were operated after neoadjuvant treatment. Adenocarcinoma was seen in 140 (80%) case operated after neoadjuvant treatment, normal colon wall was seen in 10 (5.5%) case and chronic inflammation was seen in 20 (11%) case. Conclusion: The importance of neoadjuvant treatment according to the stage of the disease in case with rectal cancer is being better understood day by day. Early surgery is recommended as the first-line treatment for early-stage rectal cancer due to its favorable outcomes. However, it has been widely accepted that in locally advanced or advanced rectal cancers with lymph node metastasis, neoadjuvant treatment before surgery is much more beneficial in terms of disease-free survival and survey after surgery
ÖZET Amaç: Crohn hastalığı, hayat boyu medikal tedavi ve takip gerektiren, tedaviye yanıt alınamadığı durumlarda veya medikal tedaviye rağmen gelişen komplikasyonların varlığında cerrahi tedavi gerekliliği olan gastrointestinal sistemin alevlenmeler ve remisyonlarla seyreden kronik enflamatuar bir hastalığıdır. Bu çalışmanın amacı; komplikasyonları sebebiyle cerrahi gerektiren Crohn hastalarının, cerrahi sonrası iyileşmelerini etkileyen faktörlerinin değerlendirilmesidir. Gereç ve Yöntem: Crohn hastalığı tanısı almış ve komplikasyonları sebebiyle ameliyat edilen hastalar değerlendirildi. Bu hastaların cerrahi sonrası iyileşmelerini etkileyecek yaş, vücut kitle indeksi (VKİ), tanı anı ile ameliyat arası süre, preoperatif Crohn hastalığı tedavisi için ilaç kullanımı, preoperatif albumin değeri, tip 2 diyabet varlığı ve sigara kullanımı retrospektif olarak incelendi. Bulgular: Çalışmaya, alınma kriterlerine uyan 24 Crohn hastalığı tanılı ve komplikasyonları sebebiyle cerrahiye alınan hasta değerlendirildi. Preoperatif albumin değeri düşük olan ve VKİ’nin